Inhibiting host-protein deposition on urinary catheters reduces associated urinary tract infections
- Department of Biological Sciences, College of Science, University of Notre Dame, United States
- Department of Chemical and Biomedical Engineering, College of Engineering, University of Maine, United States
- Graduate School of Biomedical Science and Engineering, University of Maine, United States
- Department of Chemistry and Biochemistry, College of Science, University of Notre Dame, United States
Figures
Figure 1 with 1 supplement
Uropathogens interact with fibrinogen (Fg) in vivo.
(A) Urinary catheters stained with immunofluorescence (IF) for Fg deposition (Fg; green) and microbe binding (respective pathogen; red). Unimplanted catheters were used as controls for …
Figure 1—figure supplement 1
Montages of Figure 1 merged images.
Mice were implanted and infected with 1 × 106 CFU of the respective uropathogens. At 24 hpi, bladder tissues were harvested, fixed, and parafilm embedded. Bladder were subjected to …
Figure 2 with 1 supplement
Silicone infusion and fibrinogen (Fg) enhancement of microbial surface binding.
(A–F) Uropathogens were tested for their ability to bind to protein coated and uncoated (UC) silicone catheters. For all graphs, error bars show the standard error of the mean (SEM). Between 3 and 5 …
Figure 2—figure supplement 1
Characterization of LI tubing and mouse catheters.
(A) Weight of silicone tubes were measured in designated time points before and during silicone oil infusion, the mean ( ± standard error of the mean [SEM]) of n = 5 silicone tubes over infusion …
Figure 3
Liquid-infused silicone (LIS) modification reduces fibrinogen (Fg) deposition and microbial-binding in vitro.
(A) Visualization and (B) quantification of Fg (green) deposition on unmodified (UM)-catheter material (black bars) and LIS-catheter materials (white bars) by immunofluorescence (IF) staining. Three …
Figure 4 with 1 supplement
In vivo reduction of fibrinogen (Fg) deposition to restrict microbial burden.
Mice were catheterized and infected with one of six uropathogens. (A, C, E, G, I, K) Organ and catheter CFUs from mice with either an unmodified (UM)-catheter (closed circles) or liquid-infused …
Figure 4—figure supplement 1
Pathogen predilection for fibrinogen (Fg).
Quantification of uropathogen–Fg colocalization on unmodified (UM)- and liquid-infused silicone (LIS)-catheters from mice catheterized and infected with (A) E. faecalis, (B) E. coli, (C) P. …
Figure 5 with 1 supplement
Liquid-infused silicone (LIS)-catheters reduce bladder colonization and inflammation.
Mice were catheterized and inoculated one of six strains. (A) Naive or bladders catheterized with an unmodified (UM)- or LIS-catheter were uninfected controls. (B–G) Bladder sections were stained …
Figure 5—figure supplement 1
Montage of Figure 5 merged images.
Mice were implanted with either an unmodified catheter or a liquid-infused catheter and infected with 1 × 106 CFU of the respective uropathogens. At 24 hpi, bladders tissues were harvested, fixed, …
Figure 6
Liquid-infused silicone (LIS)-catheter reduces host-protein deposition in vivo.
A subset of unmodified (UM)- and LIS-catheters taken from mice 24 hpi with E. faecalis were assessed for protein deposition via mass spectrometry four UM-catheters and five LIS-catheters were used. …
-
Figure 6—source data 1
Source data for small datasets.
Individual data from all figures involving small datasets displayed in individual tabs of this source file. This includes Figures 1B and 2A-F, Figure 3B, Figure 4, Figure 1—figure supplement 1 and Figure 2—figure supplement 1.
- https://cdn.elifesciences.org/articles/75798/elife-75798-fig6-data1-v2.zip
Figure 7
Liquid-infused silicone (LIS)-catheter reduces bladder inflammation, incidence of catheter-associated urinary tract infection (CAUTI), and dissemination.
Urinary catheter-induced inflammation promotes the release of fibrinogen (Fg) into the bladder to heal physical damage. Consequently, this Fg is deposited onto the catheter creating a scaffold for …
Tables
Key resources table
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Strain, strain background (Enterococcus faecalis) | OG1RF | ATCC | 47,077 | |
| Strain, strain background (Escherichia coli) | UTI89 | Obtained from Dr, Scott Hultgren lab | ||
| Strain, strain background (Pseudomonas aeruginosa) | PA01 | ATCC | BAA-47 | |
| Strain, strain background (Klebsiella pneumoniae) | TOP52 1721 | Obtained from Dr. Scott Hultgren lab | ||
| Strain, strain background (Acetobacter baumannii) | UPAB1 + CUP1,2 | Obtained from Dr Mario Feldman lab Di Venanzio et al., 2019 | ||
| Strain, strain background (Candida albicans) | SC5314 | ATCC | MYA-2876 | |
| Biological sample (Homosapian female) | Urine | This study | IRB #19-04-5273 | |
| Antibody | (Goat polyclonal) antifibrinogen | Sigma-Aldrich | Cat# F8512, RRID:AB_259765 | 1:1000 |
| Antibody | (Rabbit polyclonal) anti-strep group d | From Dr. Scott Hultgren lab Flores-Mireles et al., 2014 | 1:1000 (in vitro)1:500 (IHC) | |
| Antibody | (Rabbit polyclonal) anti-E. coli serotype O/K | Invitrogen | Cat# PA1-25636 RRID:AB_780488 | 1:1000 (in vitro)1:500 (IHC) |
| Antibody | (Rabbit polyclonal) anti P. aeruginosa | Invitrogen | Cat# PA173117 RRID:AB_1018279 | 1:1000 (in vitro)1:500 (IHC) |
| Antibody | (Rabbit polyclonal) anti-K. pneumoniae polyclonal | Thermo Scientific | Cat# PA17226 RRID:AB_559816 | 1:1000 (in vitro)1:500 (IHC) |
| Antibody | (Rabbit polyclonal) anti A. baumannii | Di Venanzio et al., 2019 | 1:1000 (in vitro)1:500 (IHC) | |
| Antibody | (Rabbit polyclonal) anti C. albicans | Thermo Fisher Scientific | Cat# PA1-27158 RRID:AB_779500 | 1:1000 (in vitro)1:500 (IHC) |
| Antibody | (Rat polyclonal) anti-Ly6G | BioLegend | Cat# 127602 RRID:AB_1089180 | 1:500 |
| Antibody | (Donkey polyclonal) anti-goat 800CW | LI-COR Biosciences | Cat# 926-32214, RRID:AB_621846 | 1:5000 |
| Antibody | (Donkey polyclonal) anti-rabbit 680RD | LI-COR Biosciences | Cat# 926-68073, RRID:AB_10954442 | 1:5000 |
| Antibody | (Donkey polyclonal) anti-rat 680 | Thermo Fisher | Cat# A-21472, RRID:AB_2535875 | 1:500 |
| Antibody | (Donkey polyclonal) anti-goat 488 | Thermo Fisher | Cat# A11055 RRID:AB_2534102 | 1:500 |
| Antibody | (Donkey polyclonal) anti-rabbit 550 | Thermo Fisher | Cat# A31572 RRID:AB_162543 | 1:500 |
| Peptide, recombinant protein | Fibrinogen | Enzyme Research Laboratories | Cat# FIB 3 | Adjusted to 150 µg/ml in PBS |
| Software, algorithm | Zeiss pro Software | Carl Zeiss Microscopy | ||
| Software, algorithm | Image studio software | Licor Biosciences | ||
| Other | Silicone oil | Gelest | 63148-62-9 | 20 cst |
Additional files
-
Supplementary file 1
List of proteins found on LI and UM mouse catheters infected with E. faecalis OG1RF.
The average number of peptides for each protein found on 10 mouse catheters sorted by greatest abundance on the UM-catheter.
- https://cdn.elifesciences.org/articles/75798/elife-75798-supp1-v2.xlsx
-
Supplementary file 2
Microbe details.
List of microbial strains and their corresponding growth conditions, inoculum concentrations, and antibodies used in this study
- https://cdn.elifesciences.org/articles/75798/elife-75798-supp2-v2.xlsx
-
Transparent reporting form
- https://cdn.elifesciences.org/articles/75798/elife-75798-transrepform1-v2.docx
-
Source data 1
Proteomic data from UM- and LIS-catheters.
- https://cdn.elifesciences.org/articles/75798/elife-75798-data1-v2.xlsx
